Other News To Note
• Vical Inc., of San Diego, said it inked a worldwide, nonexclusive license for rights to its Vaxfectin adjuvant to Cyvax Inc., a privately held vaccine firm, for use in malaria vaccines. Financial terms were not disclosed.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5476
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST